1. Home
  2. BOOM vs ATOS Comparison

BOOM vs ATOS Comparison

Compare BOOM & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DMC Global Inc.

BOOM

DMC Global Inc.

N/A

Current Price

$6.22

Market Cap

124.4M

Sector

Industrials

ML Signal

N/A

Logo Atossa Therapeutics Inc.

ATOS

Atossa Therapeutics Inc.

N/A

Current Price

$0.72

Market Cap

100.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BOOM
ATOS
Founded
1965
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.4M
100.8M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
BOOM
ATOS
Price
$6.22
$0.72
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$8.50
$6.33
AVG Volume (30 Days)
183.8K
1.0M
Earning Date
11-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$618,683,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.46
$0.55
52 Week High
$9.92
$1.29

Technical Indicators

Market Signals
Indicator
BOOM
ATOS
Relative Strength Index (RSI) 45.10 40.73
Support Level $6.16 $0.68
Resistance Level $6.85 $0.99
Average True Range (ATR) 0.28 0.05
MACD 0.05 -0.00
Stochastic Oscillator 40.57 10.91

Price Performance

Historical Comparison
BOOM
ATOS

About BOOM DMC Global Inc.

DMC Global Inc operates a diversified family of technical product and process businesses serving the energy, industrial and infrastructure markets. Its business is organized into three segments: Arcadia, DynaEnergetics, and NobelClad. Arcadia Products supplies architectural building products, including exterior and interior framing systems, windows, urtain walls, storefronts etc to the commercial construction market. NobelClad is involved in the production of explosion-welded clad metal plates for use in the construction of corrosion-resistant industrial processing equipment and specialized transition joints. DynaEnergetics driver, designs manufactures and distributes products utilized by the oil and gas industry principally for the perforation of oil and gas wells.

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: